Since its founding in 1984 as a multi-specialty clinical research site, Metroplex Clinical Research Center has completed more than 800 Phase I-IV clinical studies in a variety of therapeutic areas including rheumatology, osteoporosis and musculoskeletal pain. Headquartered on the campus of St. Paul Medical Center at UT Southwestern in Dallas, MCRC boasts four satellite offices serving a potential population of 1 million.
The center employs certified and trained coordinators, recruitment specialists, regulatory specialists, and laboratory technicians as well as a distinguished contingent of nine board certified rheumatologists. Medical directors Roy M. Fleischmann, M.D., and Stanley B. Cohen, M.D. have 50 years of combined clinical research experience and, between them, have published 100 scientific papers and co-authored four medical books. They are lecturers on the subjects of research and treatment of arthritis and osteoporosis and serve as advisors to major pharmaceutical companies.